Financial Statements and Related Announcement::Full Yearly Results

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
29-Aug-2025 22:37:50
Status
New
Announcement Sub Title
Full Yearly Results
Announcement Reference
SG250829OTHRII1C
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)

Please see attached.

Additional Details

For Financial Period Ended
30/06/2025

Attachments

FY2025 Results Announcement - final.pdf
iX Biopharma FY2025 Results - Press Release - final.pdf
Total size =765K